Hap Trading, LLC Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $5.95 Million - $7.06 Million	8,500 New	8,500 $6.11 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $7.55 Million - $9.33 Million	13,900 Added 64.35%	35,500 $286,000
Q3 2021 Nov 10, 2021	SELL	$574.03 - $680.96 $1.32 Million - $1.57 Million	-2,300 Reduced 9.62%	21,600 $156,000
Q2 2021 Aug 11, 2021	SELL	$472.8 - $558.54 $2.36 Million - $2.79 Million	-5,000 Reduced 17.3%	23,900 $201,000
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $3.75 Million - $4.6 Million	-8,400 Reduced 22.52%	28,900 $441,000
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $9.71 Million - $12.3 Million	20,300 Added 119.41%	37,300 $478,000
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $9.26 Million - $11.2 Million	17,000 New	17,000 $207,000
Q1 2019 May 10, 2019	SELL	$372.08 - $439.57 $4.17 Million - $4.92 Million	-11,200 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$335.82 - $403.04 $235,074 - $282,128	700 Added 6.67%	11,200 $220,000
Q3 2018 Nov 09, 2018	SELL	$351.14 - $408.51 $526,710 - $612,765	-1,500 Reduced 12.5%	10,500 $137,000
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $3.42 Million - $4.14 Million	12,000 New	12,000 $72,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.